Harbor:Sepsis antibiotics: Difference between revisions

 
(13 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Unknown Source<ref>Form v2011.09.15</ref>==
==Unknown Source<ref>Form v2011.09.15</ref>==
*'''Severe [[Sepsis]]'''
*'''Comm. Acquired'''
**Comm. Acquired
**Severe Sepsis and Septic Shock
***[[Ceftriaxone]] 1 g IV
***[[Meropenem]] 1 g IV
***[[Vancomycin]] 1 g IV
***[[Vancomycin]] 1 g IV
***[[Gentamicin]] 5mg/kg
*'''Health Care Associated'''
***[[Metronidazole]] 500mg g IV
**Severe Sepsis and Septic Shock
**Health Care Associated
***[[Meropenem]] 1 g IV
***[[Cefepime]] 2 g IV
***[[Vancomycin]] 1 g IV
***[[Gentamicin]] 5-7mg/kg
***[[Metronidazole]] 500mg g IV
*'''Septic Shock'''
**Comm. Acquired
***[[Ceftriaxone]] 1 g IV
***[[Vancomycin]] 1 g IV
***[[Gentamicin]] 5mg/kg
***[[Metronidazole]] 500mg g IV
**Health Care Associated
***[[Meropenem]] 2 g IV
***[[Vancomycin]] 1 g IV
***[[Vancomycin]] 1 g IV


Line 44: Line 32:
**'''[[Meropenam]] '''1g IV  + '''[[Levofloxacin]] '''750mg IV (Levofloxacin for synergy)
**'''[[Meropenam]] '''1g IV  + '''[[Levofloxacin]] '''750mg IV (Levofloxacin for synergy)
*'''Aspiration risk:'''  
*'''Aspiration risk:'''  
**Add [[Clindamycin]] 600 mg or [[Metronidazole]] 500 mg
**Add [[Clindamycin]] 600 mg or [[Metronidazole]] 500 mg (unless already on Meropenem)


===Healthcare Associated [[pneumonia]] (HCAP) + Hospital Associated [[pneumonia]] (HAP)===
===Healthcare Associated [[pneumonia]] (HCAP) + Hospital Associated [[pneumonia]] (HAP)===
Line 51: Line 39:


*Mild HAP/HCAP no recent antibiotic exposure:  
*Mild HAP/HCAP no recent antibiotic exposure:  
**'''[[Cefepime]] '''1g IV Q8H +/- '''[[Clindamycin]] '''600mg IV '''OR''' '''[[Metronidazole]]''' if risk of aspiration
**'''[[Cefepime]] '''1g IV Q8H  
**If risk of aspiration add '''[[Clindamycin]] '''600mg IV '''OR''' '''[[Metronidazole]]'''  
*Moderate HAP/HCAP or necrotizing [[pneumonia]]:  
*Moderate HAP/HCAP or necrotizing [[pneumonia]]:  
**Add '''[[Vancomycin]] '''for [[MRSA]]
**Add '''[[Vancomycin]] '''for [[MRSA]]
Line 63: Line 52:
==Abdominal/Pelvic==
==Abdominal/Pelvic==
*Comm. Acquired           
*Comm. Acquired           
**[[Ceftriaxone]] 1 g IV
**Severe sepsis [[Ceftriaxone]] 1 g IV + [[Metronidazole]] 500 mg IV
**[[Metronidazole]] 1.5 g IV
**Septic shock [[Ceftriaxone]] 1 g IV + [[Metronidazole]] 500 mg IV
**[[Gentamicin]] 5-7mg/kg IV
*Healthcare Assoc.           
*Healthcare Assoc.           
**[[Ceftazidime]] 2 g IV
**Severe sepsis [[Cefepime]] 1 g IV + [[Metronidazole]] 500 mg IV
**[[Gentamicin]] 5mg/kg IV
**Septic shock [[Meropenem]] 1 g IV
**[[Metronidazole]] 1.5mg IV
***If recent surgery add [[Vancomycin]] 1 g IV
*Cephalosporin allergy           
*Cephalosporin allergy           
**[[Cipro]] 400mg IV
**[[Cipro]] 400mg IV
Line 75: Line 63:
**[[Gentamicin]] 5-7mg/kg IV
**[[Gentamicin]] 5-7mg/kg IV


==Urosepsis==
==UTI with Sepsis==
*Comm. Acquired           
*Comm. Acquired           
**Severe sepsis [[Ceftriaxone]] 1 g IV
**Severe sepsis [[Ceftriaxone]] 1 g IV
Line 89: Line 77:
**[[Gentamicin]] 5mg/kg IV
**[[Gentamicin]] 5mg/kg IV


==[[Meningitis]] (Nl/Community)==
==[[Meningitis]]==


*Comm. Acquired           
*Community Acquired           
**[[Ceftriaxone]] 2 g IV
**[[Ceftriaxone]] 2 g IV
**Add [[Vancomycin]] 1 g IV if [[CSF Results]] suggest pneumococcal [[meningitis]] (for [[ceftriaxone]] resistant [[S. pneumoniae]])
**Add [[Vancomycin]] 1 g IV if [[CSF Results]] suggest pneumococcal [[meningitis]] (for [[ceftriaxone]] resistant [[S. pneumoniae]])
**Add [[Ampicillin]] 2g IV Q4H in age >50 years and pregnant
**Add [[Ampicillin]] 2g IV Q4H in age >50 years and pregnant
*[[Cephalosporin]] allergy           
**[[Cephalosporin]] allergy           
**[[Chloramphenicol]] 1 g IV
***[[Chloramphenicol]] 1 g IV
**[[Vancomycin]] 1.5g IV
***[[Vancomycin]] 1.5g IV


==[[Meningitis]] (Nl/Post neurosurgical)==
*Healthcare Assoc/Post neurosurgical
*Healthcare Assoc.         
**[[Vancomycin]] 1.5 g IV
**[[Vancomycin]] 1.5 g IV
**[[Cefepime]] 2 g IV
**[[Cefepime]] 2 g IV
*Cephalosporin allergy           
**Cephalosporin allergy           
**[[Vancomycin]] 1.5g IV
***[[Vancomycin]] 1.5g IV
**[[Cipro]] 400mg IV
***[[Cipro]] 400mg IV


==[[Meningitis]] (Immunocomp)==
*Immunocompromised (Cirrhosis, EtoH, age > 65, steroids, HIV)
(Cirrhosis, EtoH, age > 65, steroids, HIV)


*Comm. Acquired         
**[[Penicillin]] G 4M Units IV
**[[Penicillin]] G 4M Units IV
**[[Ceftriaxone]] 2 g IV
**[[Ceftriaxone]] 2 g IV
**[[Vancomycin]] 1g IV
**[[Vancomycin]] 1g IV
*Cephalosporin allergy           
**Cephalosporin allergy           
**[[Chloramphenicol]] 1g IV
***[[Chloramphenicol]] 1g IV
**[[Trim/sulfa]] 10mg/kg IV
***[[Trim/sulfa]] 10mg/kg IV
**[[Vancomycin]] 1.5g IV
***[[Vancomycin]] 1.5g IV


==[[Necrotizing Soft-tissue Infection]]==
==[[Necrotizing Soft-tissue Infection]]==
Line 136: Line 121:


==[[Neutropenic Fever]]==
==[[Neutropenic Fever]]==
*'''Severe Sepsis'''
*'''Comm. Acquired'''
**[[Cefepime]] 2 g IVPB x 1
**Severe Sepsis [[Cefepime]] 2 g IV + [[Vancomycin]] 1 g IV
**[[Vancomycin]] 1 g IVPB x 1
**Septic Shock [[Meropenem]] 1g IV + [[Vancomycin]] 1g IV
*'''Septic Shock'''
*'''Health Care Associated'''
**
**Severe Sepsis [[Cefepime]] 2 g IV + [[Vancomycin]] 1 g IV
**Septic Shock [[Meropenem]] 1g IV + [[Vancomycin]] 1g IV


==See Also==
==See Also==

Latest revision as of 23:11, 21 February 2019

Unknown Source[1]

Pneumonia

Community Acquired Pneumonia (CAP)

MCC by S. pneumoniae. In young must cover for mycoplasma and other atypicals. See Pneumonia (Pathogens)

Treatment based on Pneumonia (Port Score)

Healthcare Associated pneumonia (HCAP) + Hospital Associated pneumonia (HAP)

HAP occurs if patient develops pneumonia 2-3 days after hospitalization. HCAP occus in non-hospitalized patient with extensive healthcare contact.

Abdominal/Pelvic

UTI with Sepsis

Meningitis

  • Immunocompromised (Cirrhosis, EtoH, age > 65, steroids, HIV)

Necrotizing Soft-tissue Infection

Neutropenic Fever

See Also

Harbor:Antibiotics by diagnosis

See also Harbor: Sepsis core measures
Initial Antibiotics in Sepsis (Main)

References

  1. Form v2011.09.15